AzTrials
AzTrials

InfertilityNCT06373237

Outcome of Embryos Transferred After Initial Chaotic Results on PGT-A

An observational study of Infertility, run by Inception Fertility Research Institute, LLC at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This is a retrospective review of treatment outcomes from fertility clinics in The Prelude Network who have used Igenomix for PGT-A and have transferred embryos with initial chaotic results, regardless if re-biopsy was performed. Read more about this study

Who is it for?
Any age, women only
Conditions the study is for
Infertility
How many people
600 participants
Where
1 siteUnited States
Study dates
26 Mar 2024to 28 Apr 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Women of any age who have conducted PGT-A via Igenomix who have transferred an embryo with an initial chaotic result.

Who may be able to join

  • Patients that conducted PGT-A via Igenomix who have transferred an embryo with an initial chaotic result.

Who cannot join

  • Patients who had multiple embryo transfer.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Inception Fertility LLC

    Houston, Texas, 77081

Other trials in United States

About this study

Official title: Retrospective Observation of Outcomes of Embryos Transferred After Initial Chaotic Results on Preimplantation Genetic Testing for Aneuploidy (PGT-A)

This is a retrospective review of treatment outcomes from fertility clinics in The Prelude Network who have used Igenomix for PGT-A and have transferred embryos with initial chaotic results, regardless if re-biopsy was performed.

Read the detailed description

Primary objective: to observe the outcomes of embryos transferred with initial "chaotic" results on PGT-A via Igenomix.

Hypothesis: The transfer of chaotic embryos can result in clinical pregnancy, as defined by fetal heartbeat at 6-8 weeks gestation. Furthermore, these transfers may also result in live birth and expand reproductive potential for patients seeking IVF with PGT-A.

Conditions
Infertility
Medical subject headings
Infertility

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Embryo re-biopsy rate

    Frequency of re-biopsy post initial chaotic PGT-A result

    Measured: 2 years

  2. Embryo transfer rate

    Frequency of embryo transfer post re-biopsy

    Measured: 2 years

  3. Pregnancy rate

    Frequency of positive serum pregnancy test post embryo transfer of initial chaotic embryo

    Measured: 2 years

  4. Live birth rate

    Frequency of live birth post embryo transfer of initial chaotic embryo

    Measured: 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Apr 2024
  2. Study start26 Mar 2024
  3. Primary completion28 Apr 2025
  4. Study completion28 Apr 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
600 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06373237
Sponsor's protocol ID
INC-IG-2024-001
Status last verified
Jul 2025
First submitted
8 Apr 2024
Last updated
20 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Infertility, run by Inception Fertility Research Institute, LLC at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Embryo re-biopsy rate (time frame: 2 years). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in